A Study to Determine the Safety and Efficacy of NT-501 With MHFM
Clinical trial NCT06397131 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06397131
- Sponsor
- Neurotech Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-06
- Primary completion
- 2026-05-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.